19 Dec, 2024 Our Predictions for Life Sciences in 2025 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...
10 Dec, 2024 Life Sciences News in Italy: November 2024 By DLA Piper Life Sciences Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...
31 Oct, 2024 Medicines Australia Code of Conduct – New Edition Released By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Hazel Pang +1 more... Show less On 30 October 2024, Medicines Australia (MA) formally adopted a new edition (Edition 20) of the MA Code of Conduct (MA Code), which will...
03 Oct, 2024 Draft regulation on therapeutic use of cannabis in Spain By Elisa Lorenzo The Spanish Ministry of Health has made public this week the draft Royal Decree establishing the conditions for the elaboration and...
11 Sep, 2024 Navigating EU and national regulatory scrutiny in so called “killer acquisitions” By Alexandra Kamerling Darach Connolly Zoltan Marosi Daniel Colgan Amanda Wait +2 more... Show less The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
09 Sep, 2024 Life Sciences News in Italy: August 2024 By DLA Piper Life Sciences Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
04 Sep, 2024 Anticorruption and anti-money laundering top the UAE’s enforcement agenda: Key takeaways for the Life Sciences Sector By Adam Vause Celia Johnson-Morgan Katie Edwards Governments around the world continue to place corporate crime at the top of their enforcement agendas, and the United Arab Emirates...
09 Apr, 2024 Australia’s Second Stage Vaping Reforms Bill Introduced By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang +1 more... Show less On 21 March 2024, the second stage of Australia’s vaping reforms bill was introduced before the Australian Parliament. The Therapeutic...
04 Dec, 2023 Vapes banned from January 2024 under Australian reforms By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang Shawn Wang +2 more... Show less The Australian Federal Government has announced the first stage of Australia’s vaping reforms, which are set to commence on 1 January...
23 Nov, 2023 UK CMA publishes Competition Law Guidance for Cooperations on Combination Therapies By Alexandra Kamerling Executive Summary Combination therapies involve the use of two or more separate medicines in combination to treat a disease. It can be...
17 Nov, 2023 UK Healthcare Procurement: Provider selection regime regulations overview By Sammi King Saman Anwar Mark Vipan It is currently intended that the Provider Selection Regime (PSR) will come into force on 1 January 2024. The PSR Regulations are a new...
10 Nov, 2023 Implementation Rules of Human Genetic Resource Regulations—what it entails for life sciences clients in China By Ting Xiao Carolyn Bigg On June 1, 2023, China’s Ministry of Science and Technology (the “MOST”) issued the Implementation Rules of Administrative Regulations on...
06 Nov, 2023 The EU Foreign Subsidies Regulation - life sciences companies impacted by EC review of transactions and public procurement By Joost Haans Anna Sacco On 12 October 2023, EU Foreign Subsidies Regulation (“FSR”) filings to the European Commission (“EC”) became mandatory. In addition to...
25 Oct, 2023 Artificial Intelligence and healthcare: the Italian DPA adopts a decalogue on GDPR compliance of national healthcare services using AI By Cristina Criscuoli The use of artificial intelligence (‘AI’) systems in the pharmaceutical and healthcare sectors is growing exponentially, with...
28 Sep, 2023 Regulation and patentability of NGT plants – what’s next for the UK? By Rebecca Lawrence Dharma Carlin EU Commission Proposal On 5 July 2023, the European Commission proposed a new legislative initiative regarding plants obtained by...
29 Aug, 2023 Going green, literally – (slow) legalization of cannabis in Germany By Philip Weyand Guido Kleve Dylan Kennett Cannabis for adult-use is no longer a clandestine indulgence anymore, but a thriving industry in certain countries globally. Germany...